Restoring Biological Harmony for Patients with Debilitating Disease

We are harnessing the power of microRNA science to develop therapies that normalize biological pathways and counterbalance disease.

Learn More

DEVELOPMENT PROGRAMS

Our pipeline is focused on serious diseases of high unmet need where the latest discoveries in microRNA biology are challenging traditional drug development paradigms and creating opportunities for novel therapeutic approaches.

Learn More

Recent Press Releases

August 15, 2019: miRagen Therapeutics to Present a Corporate Overview at the Robert W. Baird & Co. 2019 Global Healthcare Conference
August 12, 2019: miRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare Conference
August 7, 2019: miRagen Reports Second Quarter 2019 Results; Regains Global Rights to MRG-110 and Announces Corporate Restructuring
July 24, 2019: Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7th
May 28, 2019: miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare Conference

View All